PET (positron emission tomography) gets Medicare thumbs down for breast cancer screening
This article was originally published in Clinica
Executive Summary
A panel of experts that advises the federal government on Medicare coverage issues has found little reason to recommend the use of positron emission tomography (PET) in evaluating breast cancer.